Literature DB >> 8424460

Fibroblast migration in fibrin gel matrices.

L F Brown1, N Lanir, J McDonagh, K Tognazzi, A M Dvorak, H F Dvorak.   

Abstract

In healing wounds and many solid tumors, locally increased microvascular permeability results in extravasation of fibrinogen and its extravascular coagulation to form a fibrin gel, with concomitant covalent cross-linking of fibrin by factor XIIIa. Subsequently, inflammatory cells, fibroblasts, and endothelial cells migrate into the gel and organize it into granulation tissue and later into mature collagenous connective tissue. To gain insight into some of the cell migration events associated with these processes, we developed a quantitative in vitro assay that permits the study of fibroblast migration in fibrin gels. Early passage human or rat fibroblasts were allowed to attach to tissue culture dishes and then were overlaid with a thin layer of fibrinogen that was clotted with thrombin. Fibroblasts began to migrate upwards into the fibrin within 24 hours and their numbers and the distance migrated were quantified over several days. The extent of fibroblast migration was affected importantly by the nature of the fibrin clot. Fibroblasts migrated optimally into gels prepared from fibrinogen at concentrations of -3 mg/ml; ie, near normal plasma fibrinogen levels. Migration was greatly enhanced by extensive cross-linking of the fibrin alpha-chains by factor XIIIa, as occurs when clotting takes place in vivo. When fibrinogen was clotted in Dulbecco's modified Eagle's medium, gamma-chains were cross-linked, but alpha-chain cross-linking was strikingly inhibited, and fibroblasts migrated poorly. Gels prepared from factor XIII-depleted fibrinogen exhibited neither alpha-nor gamma-chain cross-linking and did not support fibroblast migration. Further purification of fibrinogen by anion exchange high pressure liquid chromatography depleted fibrinogen of fibronectin, plasminogen, and other impurities; this purified fibrinogen clotted to form fibrin gels that supported reproducible fibroblast migration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424460      PMCID: PMC1886838     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing.

Authors:  E BECK; F DUCKERT; M ERNST
Journal:  Thromb Diath Haemorrh       Date:  1961-12-15

2.  Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration.

Authors:  N Lanir; P S Ciano; L Van de Water; J McDonagh; A M Dvorak; H F Dvorak
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

3.  Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing.

Authors:  H F Dvorak; V S Harvey; P Estrella; L F Brown; J McDonagh; A M Dvorak
Journal:  Lab Invest       Date:  1987-12       Impact factor: 5.662

4.  Electron microscopy and hydrodynamic properties of factor XIII subunits.

Authors:  N A Carrell; H P Erickson; J McDonagh
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

Review 5.  Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

Authors:  J A Nagy; L F Brown; D R Senger; N Lanir; L Van de Water; A M Dvorak; H F Dvorak
Journal:  Biochim Biophys Acta       Date:  1989-02

6.  Cultures of fibroblasts in fibrin lattices: models for the study of metabolic activities of the cells in physiological conditions.

Authors:  P Gillery; G Bellon; F Coustry; J P Borel
Journal:  J Cell Physiol       Date:  1989-09       Impact factor: 6.384

7.  [Speeding wound healing by blood clotting factor XIII].

Authors:  H Biel; H Bohn; H Ronneberger; O Zwisler
Journal:  Arzneimittelforschung       Date:  1971-10

8.  Fibronectin and fibrinolysis are not required for fibrin gel contraction by human skin fibroblasts.

Authors:  T L Tuan; F Grinnell
Journal:  J Cell Physiol       Date:  1989-09       Impact factor: 6.384

9.  Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas.

Authors:  L F Brown; B Asch; V S Harvey; B Buchinski; H F Dvorak
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

10.  Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights.

Authors:  C W Francis; D H Kraus; V J Marder
Journal:  Biochim Biophys Acta       Date:  1983-04-28
View more
  51 in total

1.  Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.

Authors:  E Gandossi; C Lunven; C N Berry
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma.

Authors:  Harold F Dvorak
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

3.  A novel in vitro dermal wound-healing model incorporating a response to mechanical wounding and repopulation of a fibrin provisional matrix.

Authors:  R O'Leary; E J Wood
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

4.  Bone tissue engineering with bone marrow-derived stromal cells integrated with concentrated growth factor in Rattus norvegicus calvaria defect model.

Authors:  Hirotsugu Honda; Noriyuki Tamai; Norifumi Naka; Hideki Yoshikawa; Akira Myoui
Journal:  J Artif Organs       Date:  2013-05-23       Impact factor: 1.731

Review 5.  Fibrin gels and their clinical and bioengineering applications.

Authors:  Paul A Janmey; Jessamine P Winer; John W Weisel
Journal:  J R Soc Interface       Date:  2009-01-06       Impact factor: 4.118

6.  CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix.

Authors:  C A Henke; U Roongta; D J Mickelson; J R Knutson; J B McCarthy
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  Fibrinogen regulates the cytotoxicity of mycobacterial trehalose dimycolate but is not required for cell recruitment, cytokine response, or control of mycobacterial infection.

Authors:  Kaori Sakamoto; Rachel E Geisel; Mi-Jeong Kim; Bryce T Wyatt; Llewelyn B Sellers; Stephen T Smiley; Andrea M Cooper; David G Russell; Elizabeth R Rhoades
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

8.  Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease.

Authors:  C Henke; P Bitterman; U Roongta; D Ingbar; V Polunovsky
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

9.  A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor.

Authors:  Jasmina Profirovic; Elena Strekalova; Norifumi Urao; Aleksandar Krbanjevic; Alexandra V Andreeva; Sudhahar Varadarajan; Tohru Fukai; René Hen; Masuko Ushio-Fukai; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2012-08-18       Impact factor: 9.596

10.  Plasminogen activation in healing human wounds.

Authors:  B M Schäfer; K Maier; U Eickhoff; R F Todd; M D Kramer
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.